Global Onychomycosis Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 307045
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Onychomycosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Onychomycosis Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Onychomycosis Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Medication segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Onychomycosis Treatment include Pfizer, Novartis, Johnson & Johnson, Bausch Health, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Onychomycosis Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Medication

Lasers

Photodynamic Therapy

Market segment by Application, can be divided into

Hospitals

Dermatology Clinics

Retail Pharmacies

Online Pharmacies

Market segment by players, this report covers

Pfizer

Novartis

Johnson & Johnson

Bausch Health

Bayer

Lumenis

Galderma

Moberg Pharma

Cipla

Biofrontera

Leo Pharma

Dr. Reddy's Laboratories

Medimetriks Pharmaceuticals

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Onychomycosis Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Onychomycosis Treatment, with revenue, gross margin and global market share of Onychomycosis Treatment from 2019 to 2022.

Chapter 3, the Onychomycosis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Onychomycosis Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Onychomycosis Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Onychomycosis Treatment

1.2 Classification of Onychomycosis Treatment by Type

1.2.1 Overview: Global Onychomycosis Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Onychomycosis Treatment Revenue Market Share by Type in 2021

1.2.3 Medication

1.2.4 Lasers

1.2.5 Photodynamic Therapy

1.3 Global Onychomycosis Treatment Market by Application

1.3.1 Overview: Global Onychomycosis Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Dermatology Clinics

1.3.4 Retail Pharmacies

1.3.5 Online Pharmacies

1.4 Global Onychomycosis Treatment Market Size & Forecast

1.5 Global Onychomycosis Treatment Market Size and Forecast by Region

1.5.1 Global Onychomycosis Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Onychomycosis Treatment Market Size by Region, (2017-2022)

1.5.3 North America Onychomycosis Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Onychomycosis Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Onychomycosis Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Onychomycosis Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Onychomycosis Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Onychomycosis Treatment Market Drivers

1.6.2 Onychomycosis Treatment Market Restraints

1.6.3 Onychomycosis Treatment Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Onychomycosis Treatment Product and Solutions

2.1.4 Pfizer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Onychomycosis Treatment Product and Solutions

2.2.4 Novartis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Johnson & Johnson

2.3.1 Johnson & Johnson Details

2.3.2 Johnson & Johnson Major Business

2.3.3 Johnson & Johnson Onychomycosis Treatment Product and Solutions

2.3.4 Johnson & Johnson Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Johnson & Johnson Recent Developments and Future Plans

2.4 Bausch Health

2.4.1 Bausch Health Details

2.4.2 Bausch Health Major Business

2.4.3 Bausch Health Onychomycosis Treatment Product and Solutions

2.4.4 Bausch Health Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Bausch Health Recent Developments and Future Plans

2.5 Bayer

2.5.1 Bayer Details

2.5.2 Bayer Major Business

2.5.3 Bayer Onychomycosis Treatment Product and Solutions

2.5.4 Bayer Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Bayer Recent Developments and Future Plans

2.6 Lumenis

2.6.1 Lumenis Details

2.6.2 Lumenis Major Business

2.6.3 Lumenis Onychomycosis Treatment Product and Solutions

2.6.4 Lumenis Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Lumenis Recent Developments and Future Plans

2.7 Galderma

2.7.1 Galderma Details

2.7.2 Galderma Major Business

2.7.3 Galderma Onychomycosis Treatment Product and Solutions

2.7.4 Galderma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Galderma Recent Developments and Future Plans

2.8 Moberg Pharma

2.8.1 Moberg Pharma Details

2.8.2 Moberg Pharma Major Business

2.8.3 Moberg Pharma Onychomycosis Treatment Product and Solutions

2.8.4 Moberg Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Moberg Pharma Recent Developments and Future Plans

2.9 Cipla

2.9.1 Cipla Details

2.9.2 Cipla Major Business

2.9.3 Cipla Onychomycosis Treatment Product and Solutions

2.9.4 Cipla Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Cipla Recent Developments and Future Plans

2.10 Biofrontera

2.10.1 Biofrontera Details

2.10.2 Biofrontera Major Business

2.10.3 Biofrontera Onychomycosis Treatment Product and Solutions

2.10.4 Biofrontera Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Biofrontera Recent Developments and Future Plans

2.11 Leo Pharma

2.11.1 Leo Pharma Details

2.11.2 Leo Pharma Major Business

2.11.3 Leo Pharma Onychomycosis Treatment Product and Solutions

2.11.4 Leo Pharma Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Leo Pharma Recent Developments and Future Plans

2.12 Dr. Reddy's Laboratories

2.12.1 Dr. Reddy's Laboratories Details

2.12.2 Dr. Reddy's Laboratories Major Business

2.12.3 Dr. Reddy's Laboratories Onychomycosis Treatment Product and Solutions

2.12.4 Dr. Reddy's Laboratories Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Dr. Reddy's Laboratories Recent Developments and Future Plans

2.13 Medimetriks Pharmaceuticals

2.13.1 Medimetriks Pharmaceuticals Details

2.13.2 Medimetriks Pharmaceuticals Major Business

2.13.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Product and Solutions

2.13.4 Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Medimetriks Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Onychomycosis Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Onychomycosis Treatment Players Market Share in 2021

3.2.2 Top 10 Onychomycosis Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Onychomycosis Treatment Players Head Office, Products and Services Provided

3.4 Onychomycosis Treatment Mergers & Acquisitions

3.5 Onychomycosis Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Onychomycosis Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Onychomycosis Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Onychomycosis Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Onychomycosis Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Onychomycosis Treatment Revenue by Type (2017-2028)

6.2 North America Onychomycosis Treatment Revenue by Application (2017-2028)

6.3 North America Onychomycosis Treatment Market Size by Country

6.3.1 North America Onychomycosis Treatment Revenue by Country (2017-2028)

6.3.2 United States Onychomycosis Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Onychomycosis Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Onychomycosis Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Onychomycosis Treatment Revenue by Type (2017-2028)

7.2 Europe Onychomycosis Treatment Revenue by Application (2017-2028)

7.3 Europe Onychomycosis Treatment Market Size by Country

7.3.1 Europe Onychomycosis Treatment Revenue by Country (2017-2028)

7.3.2 Germany Onychomycosis Treatment Market Size and Forecast (2017-2028)

7.3.3 France Onychomycosis Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Onychomycosis Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Onychomycosis Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Onychomycosis Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Onychomycosis Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Onychomycosis Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Onychomycosis Treatment Market Size by Region

8.3.1 Asia-Pacific Onychomycosis Treatment Revenue by Region (2017-2028)

8.3.2 China Onychomycosis Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Onychomycosis Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Onychomycosis Treatment Market Size and Forecast (2017-2028)

8.3.5 India Onychomycosis Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Onychomycosis Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Onychomycosis Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Onychomycosis Treatment Revenue by Type (2017-2028)

9.2 South America Onychomycosis Treatment Revenue by Application (2017-2028)

9.3 South America Onychomycosis Treatment Market Size by Country

9.3.1 South America Onychomycosis Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Onychomycosis Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Onychomycosis Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Onychomycosis Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Onychomycosis Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Onychomycosis Treatment Market Size by Country

10.3.1 Middle East & Africa Onychomycosis Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Onychomycosis Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Onychomycosis Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Onychomycosis Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Onychomycosis Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Onychomycosis Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Onychomycosis Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Onychomycosis Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Onychomycosis Treatment Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Onychomycosis Treatment Product and Solutions

Table 9. Pfizer Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Onychomycosis Treatment Product and Solutions

Table 13. Novartis Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 15. Johnson & Johnson Major Business

Table 16. Johnson & Johnson Onychomycosis Treatment Product and Solutions

Table 17. Johnson & Johnson Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Bausch Health Corporate Information, Head Office, and Major Competitors

Table 19. Bausch Health Major Business

Table 20. Bausch Health Onychomycosis Treatment Product and Solutions

Table 21. Bausch Health Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Bayer Corporate Information, Head Office, and Major Competitors

Table 23. Bayer Major Business

Table 24. Bayer Onychomycosis Treatment Product and Solutions

Table 25. Bayer Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Lumenis Corporate Information, Head Office, and Major Competitors

Table 27. Lumenis Major Business

Table 28. Lumenis Onychomycosis Treatment Product and Solutions

Table 29. Lumenis Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Galderma Corporate Information, Head Office, and Major Competitors

Table 31. Galderma Major Business

Table 32. Galderma Onychomycosis Treatment Product and Solutions

Table 33. Galderma Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Moberg Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Moberg Pharma Major Business

Table 36. Moberg Pharma Onychomycosis Treatment Product and Solutions

Table 37. Moberg Pharma Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Cipla Corporate Information, Head Office, and Major Competitors

Table 39. Cipla Major Business

Table 40. Cipla Onychomycosis Treatment Product and Solutions

Table 41. Cipla Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Biofrontera Corporate Information, Head Office, and Major Competitors

Table 43. Biofrontera Major Business

Table 44. Biofrontera Onychomycosis Treatment Product and Solutions

Table 45. Biofrontera Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Leo Pharma Corporate Information, Head Office, and Major Competitors

Table 47. Leo Pharma Major Business

Table 48. Leo Pharma Onychomycosis Treatment Product and Solutions

Table 49. Leo Pharma Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Dr. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors

Table 51. Dr. Reddy's Laboratories Major Business

Table 52. Dr. Reddy's Laboratories Onychomycosis Treatment Product and Solutions

Table 53. Dr. Reddy's Laboratories Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Medimetriks Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Medimetriks Pharmaceuticals Major Business

Table 56. Medimetriks Pharmaceuticals Onychomycosis Treatment Product and Solutions

Table 57. Medimetriks Pharmaceuticals Onychomycosis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Onychomycosis Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Onychomycosis Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Onychomycosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Onychomycosis Treatment Players Head Office, Products and Services Provided

Table 62. Onychomycosis Treatment Mergers & Acquisitions in the Past Five Years

Table 63. Onychomycosis Treatment New Entrants and Expansion Plans

Table 64. Global Onychomycosis Treatment Revenue (USD Million) by Type (2017-2022)

Table 65. Global Onychomycosis Treatment Revenue Share by Type (2017-2022)

Table 66. Global Onychomycosis Treatment Revenue Forecast by Type (2023-2028)

Table 67. Global Onychomycosis Treatment Revenue by Application (2017-2022)

Table 68. Global Onychomycosis Treatment Revenue Forecast by Application (2023-2028)

Table 69. North America Onychomycosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Onychomycosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Onychomycosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Onychomycosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Onychomycosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Onychomycosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Onychomycosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Onychomycosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Onychomycosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Onychomycosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Onychomycosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Onychomycosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Onychomycosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Onychomycosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Onychomycosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Onychomycosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Onychomycosis Treatment Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Onychomycosis Treatment Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Onychomycosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Onychomycosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Onychomycosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Onychomycosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Onychomycosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Onychomycosis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Onychomycosis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Onychomycosis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Onychomycosis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Onychomycosis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Onychomycosis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Onychomycosis Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Onychomycosis Treatment Picture

Figure 2. Global Onychomycosis Treatment Revenue Market Share by Type in 2021

Figure 3. Medication

Figure 4. Lasers

Figure 5. Photodynamic Therapy

Figure 6. Onychomycosis Treatment Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Dermatology Clinics Picture

Figure 9. Retail Pharmacies Picture

Figure 10. Online Pharmacies Picture

Figure 11. Global Onychomycosis Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Onychomycosis Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Onychomycosis Treatment Revenue Market Share by Region (2017-2028)

Figure 14. Global Onychomycosis Treatment Revenue Market Share by Region in 2021

Figure 15. North America Onychomycosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Onychomycosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Onychomycosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Onychomycosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Onychomycosis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Onychomycosis Treatment Market Drivers

Figure 21. Onychomycosis Treatment Market Restraints

Figure 22. Onychomycosis Treatment Market Trends

Figure 23. Pfizer Recent Developments and Future Plans

Figure 24. Novartis Recent Developments and Future Plans

Figure 25. Johnson & Johnson Recent Developments and Future Plans

Figure 26. Bausch Health Recent Developments and Future Plans

Figure 27. Bayer Recent Developments and Future Plans

Figure 28. Lumenis Recent Developments and Future Plans

Figure 29. Galderma Recent Developments and Future Plans

Figure 30. Moberg Pharma Recent Developments and Future Plans

Figure 31. Cipla Recent Developments and Future Plans

Figure 32. Biofrontera Recent Developments and Future Plans

Figure 33. Leo Pharma Recent Developments and Future Plans

Figure 34. Dr. Reddy's Laboratories Recent Developments and Future Plans

Figure 35. Medimetriks Pharmaceuticals Recent Developments and Future Plans

Figure 36. Global Onychomycosis Treatment Revenue Share by Players in 2021

Figure 37. Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Onychomycosis Treatment Revenue Market Share in 2021

Figure 39. Global Top 10 Players Onychomycosis Treatment Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Onychomycosis Treatment Revenue Share by Type in 2021

Figure 42. Global Onychomycosis Treatment Market Share Forecast by Type (2023-2028)

Figure 43. Global Onychomycosis Treatment Revenue Share by Application in 2021

Figure 44. Global Onychomycosis Treatment Market Share Forecast by Application (2023-2028)

Figure 45. North America Onychomycosis Treatment Sales Market Share by Type (2017-2028)

Figure 46. North America Onychomycosis Treatment Sales Market Share by Application (2017-2028)

Figure 47. North America Onychomycosis Treatment Revenue Market Share by Country (2017-2028)

Figure 48. United States Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Onychomycosis Treatment Sales Market Share by Type (2017-2028)

Figure 52. Europe Onychomycosis Treatment Sales Market Share by Application (2017-2028)

Figure 53. Europe Onychomycosis Treatment Revenue Market Share by Country (2017-2028)

Figure 54. Germany Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Onychomycosis Treatment Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Onychomycosis Treatment Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Onychomycosis Treatment Revenue Market Share by Region (2017-2028)

Figure 62. China Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Onychomycosis Treatment Sales Market Share by Type (2017-2028)

Figure 69. South America Onychomycosis Treatment Sales Market Share by Application (2017-2028)

Figure 70. South America Onychomycosis Treatment Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Onychomycosis Treatment Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Onychomycosis Treatment Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Onychomycosis Treatment Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Onychomycosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz